DCOY Decoy Therapeutics Inc.

$DCOY $DCOY Next-Gen AI Tech is ALIVE! 🚨 PAN-FILOVIRUS BREAKTHROUGH! Decoy just proved their IMP³ACT™ AI-engine is a beast. 🔥 Ebola Zaire: 7x MORE potent than Remdesivir! 🔥 Marburg Virus: Massive 1.04 μM cross-activity! 🔥 FDA Animal Rule: Fast & cheap regulatory pathway. No massive human trials needed. 💎 The Real Gold: Targeting the FDA Priority Review Voucher (PRV). Big Pharma is paying $180M–$205M cash for these right now. Decoy’s market cap is a fraction of that! Government biodefense grants & non-dilutive funding are coming next. Loading up before tier-1 contracts drop! 📈🌋 #Biotech #AI #Bullish

$DCOY 🚀 BOMB 💣 New Ebola + Marburg drug 5x & 7x stronger than Remdesivir, FDA fast-track. PRV worth $100-180M if approved! We could see crazy run like $JAGX!

$DCOY was the highlight of my day yesterday, and although it made a little curl today off of my watchlist plan last night, it never really gave me the setup I was looking for... Nonetheless, it's back on watch for tomorrow... similar plan, but I'll need to see a S/D flip + VWAP Reclaim as shown below prior to considering any entries. No reclaim, no break, no trade! Range to $4.8, $5.2, $7.00+

$DCOY market cap now below $3 millions which is less than 1/3 of cash on balance sheet it doesnt make sense oh well

$DCOY was an absolute printer this morning, and if it can reclaim VWAP/break over local supply (S/D flip) tomorrow morning, I'll play ball for the curl back through today's sell off range. No reclaim, no break, no trade! Range to $5/$6/$7+

$DCOY $PFSA if you understand what a bull flag is, then you will be PATIENT. No worries. Its a perfect time to average down.

$DCOY A huge short squeeze will start soon- Target $20 Let that sink in. 👀🧬 🚨 PAN FILOVIRUS BREAKTHROUGH! Decoy just proved their IMP³ACT™ AI engine is a beast. 🔥 Ebola Zaire: 7x MORE potent than Remdesivir! 🔥 Marburg Virus: Massive 1.04 μM cross-activity! 🔥 FDA Animal Rule: Fast & cheap regulatory pathway. No massive human trials needed. Pan-filovirus program targeting multiple deadly viruses 💎 The Real Gold: Targeting the FDA Priority Review Voucher (PRV). Big Pharma is paying $180M–$205M cash for these right now. Decoy's market cap is a fraction of that! Government biodefense grants & non-dilutive funding are coming next. Loading up before tier-1 contracts drop!

$DCOY if they get non dilutive grant $$ watch out 🚀 CAMBRIDGE, Mass., Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY), a biotechnology company pioneering Designable Multi-Antivirals (D-MAVs™) to target major respiratory and high consequence viral threats, today announced a refined corporate strategy to explore its D-MAVs for additional candidates, including a pan-filovirus program along the U.S. Food and Drug Administration (FDA) Animal Rule pathway for expedited regulatory approval. Based on recent encouraging discussions, the Company is actively pursuing non-dilutive government grants and public health partnerships to support the preclinical and clinical development of its broad-spectrum biodefense pipeline with monetization potential upon approval via Priority Review Voucher (PRV) opportunities.

$DCOY Decoy Therapeutics Reports Preclinical Data Supporting Once-Weekly Intranasal Dosing for DCOY-CoV Program

$DCOY DCOY-CoV — the pan-coronavirus product That’s the one I would put at the top of the list for a potential $1 billion annual-sales opportunity—if it works in humans and eventually gets approved. DCOY itself points to the size of the opportunity: its presentation cites $5.7 billion in Paxlovid sales in 2024 and estimates about 20 million immunocompromised people in the U.S. and EU as a core target population. The idea is bigger than just COVID: * DCOY-CoV is designed to target multiple coronaviruses. * DCOY says its candidates have shown activity against the human coronaviruses it has tested. * It is being developed as an inhaled/nasal antiviral, potentially for prevention and treatment. * The company expects to start a Phase 1 study in 2027. 👍

$DCOY Remember, no day trading—just buy and hold, and we’ll quickly hit $10–$15. Day trading helps the shorts. DON'T do it if you want to get rich.

$DCOY loving this chart. A little higher every few hours! All we need and then the rocket blows! In for the day! Good luck all!

$DCOY These shorts owe me a lot more money. I have all the time in the world I’ll wait Current mood while I wait is zen state af This thing is going to rip our faces up when it starts moving upwards again

$DCOY this stock is a dead end. tomorrow will be huge red, last time it felly by 25% with dilution. Avoid bull messages and save money.

$DCOY BUY THE DIP 🔥 DCOY is positioned for a powerful move, with a setup that could mirror what we saw in $JAGX. This level deserves serious attention — the momentum move could come fast. 👀🚀

$DCOY This held pretty strong on a Friday ! I’d love to see this go parabolic throughout next week!!! 🚀🚀🚀🚀🚀🚀

$DCOY $MSS I was early on MSS and early on $VSA Live Algo data beats charts and delayed scanners I copy smart money/algo moves hence no guessing/gambling ✅ I post Quality over Quantity. 🎯🎯 You are destined to be RICH RICH 🤑💰, nfa

$DCOY congratulations to all of my followers that followed me purchased yesterday we made bucks $$$ took gains at $4.50 this am

$DCOY you will lose your ass if you hold this overnight. Huge gap down below! 2 million warrants that they can execute right now!

$DCOY the premium from today's catalyst hasn't even been baked in yet. Short squeeze is inevitable. We need the shorts as rocket fuel.